This suggests that in HTLV-1 infection, HBZ, which is differentially localized in MT-2 and SLB-1 cells, may act as a leukemogenic stimulator that inhibits the tumor-suppressive activity of Menin and promotes JunD-mediated leukemogenesis. Here, MEN1 is linked to neoplasm.